Cost-Sharing for Part B Chemotherapy Drugs in Medicare Advantage Plans: an Administrative Data Analysis.
Cost-Sharing for Part B Chemotherapy Drugs in Medicare Advantage Plans: an Administrative Data Analysis.
复制标题
医疗保险优势计划中 B 部分化疗药物的费用分摊：行政数据分析。
DOI：
10.1007/s11606-019-04863-5
复制
发表时间：
2019
影响因子：
5.7
通讯作者：
Finch,ChristopherJ
中科院分区：
文献类型：
--
作者：
Keohane,LauraM;Finch,ChristopherJ
方法医疗保险和医疗补助服务中心 (CMS) 公开报告 MA 计划的年度费用分摊信息、每月的注册统计数据和计划类型。 5 我们结合了 2008-2018 年的这些数据集，以确定 MA 健康维护组织和首选提供者组织计划成员的 B 部分化疗益处。计划注册人数基于 2008-2017 年 12 月和 2018 年 2 月的总数。我们排除了团体（包括雇主和工会）赞助的计划、特殊需求计划以及参保人数少于 10 人的计划。
METHODSThe Centers for Medicare and Medicaid Services (CMS) publicly reports MA plans’ annual cost-sharing information, monthly enrollment statistics, and plan type. 5 We combined these data sets for the years 2008–2018 to identify Part B chemotherapy benefits for members of MA Health Maintenance Organization and Preferred Provider Organization plans. Plan enrollment numbers are based on December totals for the years 2008–2017 and February for 2018. We excluded plans sponsored by groups (including employers and unions), Special Needs Plans, and plans with fewer than 10 enrollees.